PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.1215
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Anastrozole, in Comparison With Tamoxifen, in the Adjuvant Treatment of Early Breast Cancer in Brazil

Revista da Associacao Medica Brasileira
Medicine
2009English

Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment

Clinical Drug Investigation
MedicinePharmacology
2017English

Cyclophosphamide and Tamoxifen as Adjuvant Therapies in the Management of Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1988English

Adjuvant Bisphosphonates in Breast Cancer Treatment

Breast Care
SurgeryOncology
2014English

Taxanes in Adjuvant Breast Cancer Treatment

Libri Oncologici
Oncology
2018English

Cost Considerations in Determining the Affordability of Adjuvant Trastuzumab in Breast Cancer

South African Medical Journal
Medicine
2016English

Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Cost-Utility Analysis of Adjuvant Therapies for Breast Cancer in Iran

International Journal of Technology Assessment in Health Care
Health Policy
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy